ICMAS · Registering as Listener

International Conference on Microbiology and Antiviral Strategies

18th Dec – 19th Dec 2026 Vienna, Austria Standard / Physical Participation
Listener Registration From
$—
$— in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

For Support Please Contact

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply
VISA MC AMEX UPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICMAS
ModeStandard / Physical
ParticipationListener
Registration fee$—
Bank charges (5.8%)$—
Discount-$0.00
Total payable $—

Includes all bank processing charges — the amount above is exactly what will be charged. View charge breakdown

Need help?

Contact our registration team:

Benefits of Registering as Listener
Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
Conference Session Tracks
SDG Wheel

SDG-Aligned Research Themes

International Conference on Microbiology and Antiviral Strategies conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 6 - Clean Water and Sanitation SDG 9 - Industry, Innovation and Infrastructure

This track will explore the latest innovations in molecular diagnostic techniques for infectious diseases. Emphasis will be placed on the integration of these methods into clinical practice to enhance patient outcomes.

This session will focus on novel antiviral strategies and their mechanisms of action against various pathogens. Participants will discuss the potential for these strategies to reshape the landscape of infectious disease treatment.

This track will highlight recent clinical research findings related to infectious diseases and their implications for public health. Discussions will include challenges faced in clinical trials and strategies for effective patient management.

This session will address the critical role of translational research in bridging laboratory discoveries with clinical applications in microbiology. Participants will share insights on successful case studies and future directions in this field.

This track will showcase cutting-edge laboratory techniques that enhance the study of microbiological agents. Emphasis will be placed on methodologies that improve accuracy, efficiency, and safety in laboratory settings.

This session will delve into the pressing issue of antimicrobial resistance and its impact on public health. Experts will discuss innovative approaches to combat resistance and promote effective antimicrobial stewardship.

This track will focus on in-depth studies of various pathogens, exploring their mechanisms of infection and host interactions. The session aims to foster discussions on potential therapeutic targets and prevention strategies.

This session will highlight recent therapeutic innovations aimed at improving the management of infectious diseases. Participants will discuss the efficacy and safety of new treatments and their implications for clinical practice.

This track will explore the relationship between microbial ecology and human health, including the role of the microbiome in disease prevention and treatment. Discussions will focus on how ecological factors influence microbial behavior and health outcomes.

This session will examine current vaccination strategies and their effectiveness in preventing infectious diseases. Participants will discuss the challenges of vaccine development and deployment in diverse populations.

This track will address the global health implications of infectious diseases and the collaborative efforts required to combat them. Emphasis will be placed on international research initiatives and policy frameworks that support public health.

COPYRIGHT © 2026 International Conference on Microbiology and Antiviral Strategies. ALL RIGHTS RESERVED